SCHEMBL6202704

SCHEMBL6202704

CCCOc1cccc2c1Cc1c-2n[nH]c1Nc1cccc(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 4/20 0.41
EGFR P00533 12/20 0.41
PRKCA P17252 9/20 0.41
ABL1 P00519 8/20 0.41
SRC P12931 7/20 0.41
CDK1 P06493 3/20 0.41
PDGFRA P16234 2/20 0.40
STK10 O94804 1/20 0.39
CLK2 P49760 1/20 0.39
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
STK33 Q9BYT3 1/20 0.39
SLK Q9H2G2 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
TLK1 Q9UKI8 1/20 0.39
FBP1 P09467 1/20 0.38
JAK2 O60674 1/20 0.37
PTK2 Q05397 1/20 0.37
MAPT P10636 2/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4041498 0.89 EGFR (0.39) PDGFRBEGFRPRKCAABL1SRC
SCHEMBL4048781 0.89 PLK1 (0.40) PDGFRBEGFRPRKCAABL1SRC
SCHEMBL4041506 0.83 EGFR (0.50) EGFRSRCGSK3AGSK3BMAPT
SCHEMBL4051929 0.80 LMNA (0.36) PDGFRBMAPTALDH1A1
SCHEMBL4044208 0.78 PDGFRB (0.52) PDGFRBEGFRPRKCAABL1SRC
SCHEMBL13145876 0.78 PDGFRB (0.38) PDGFRBEGFRPRKCAABL1SRC
SCHEMBL4045621 0.77 KDR (0.39) PDGFRBEGFRABL1SRCPDGFRA
SCHEMBL4043884 0.77 PDGFRB (0.39) PDGFRBEGFRABL1SRCCDK1
SCHEMBL4052012 0.77 HIF1A (0.43) PDGFRBEGFRPRKCAABL1SRC
SCHEMBL4044937 0.77 PDGFRB (0.47) PDGFRBEGFRPRKCAABL1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP claimed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO claimed